* New or Updated Deadlines or Notifications
Abstracts are not required for conference registration and attendance, however they are strongly encouraged and are required if you wish to be considered for registration scholarships and travel grants, posters and selection of oral presentations.
[NOTE: To apply for a registration scholarship and/or travel grant, or to review eligibility, please visit the Scholarships page.]
All submitted abstracts will be reviewed by the Scientific Organizing Committee (SOC) and considered for selection of a 15-minute oral or poster presentation. Only a limited number of oral and poster presentations will be offered, however all submitted abstracts will be published in the conference program. Abstract review criteria are provided below.
Presenting authors are responsible for submitting their abstracts via the Abstract Submission Webform below. Presenting authors may only submit one abstract for consideration.
Quick Link: Abstract Submission Webform
Read below for abstract preparation and review guidelines.
* Abstract Submission Deadline: June 16, 2014
* Late Breaking Abstract Submission Deadline: July 16, 2014
Final Notification Dates
Oral Presentations: July 1, 2014
July 15, 2014 July 1, 2014
* Late Breaking Abstract Notification: July 29, 2014
Should contain the following components:
- Title, Authors/Affiliations, Background, Methods, Results, Conclusion
Should not contain tables or figures.
Must be submitted in English as a MS Word document.
Abstracts should be no longer than 350 words in length. The abstract title and author names/affiliations are excluded from the word limit.
The title should be short and concise while describing the content of the abstract. The title is limited to 30 words.
Author names should be presented using initial(s) for the first and middle names followed by the full last name. The presenting author should be listed first.
AB Author1, CD Author2 and EF Author3
Author affiliations should be presented as follows:
1 AB Author Affiliation, City, State/Province, Country; 2 CD Author Affiliation, City, State/Province, Country; 3 EF Author Affiliation, City, State/Province, Country
1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 2 Institut Pasteur, Paris, France; and 3 Sangamo BioSciences, Richmond, CA, USA.
Describe what is known/unknown about the subject, and what the study intends to investigate (hypothesis).
Describe what experimental methods were used to generate the results, and how.
Provide a summary of your research findings.
Provide a summary of your relevant findings and their implications to the field.
Please review the abstract review criteria below prior to submitting your abstract.
Click here to proceed to the Abstract Submission Webform.
Abstract-Driven Posters, Oral Presentations
Submitted abstracts will be reviewed by the SOC for selection of poster or oral presentations. A limited number of poster and oral presentations will be selected. If an abstract is not chosen for presentation, it will still be published in the conference program.
Presenting authors can choose to opt out of consideration for an oral presentation during the Abstract submission process, if they desire.
Criteria for Abstract Review
- Relevance to the meeting topic: Cell & Gene Therapy for HIV Cure
- Significance of the scientific question and results
- Organization (e.g., the abstract has a clear beginning, middle and end)
- Grammar and spelling
- Clarity of scientific presentations
- Clear question or hypothesis
- Sufficient background
- The experimental approach and rationale for the approach are clear
- The results are clearly presented
- The interpretation and conclusions are reasonable and logical
Final Notification Dates
- Oral presentations – July 1, 2014.
- Poster presentations – July 1, 2014.
Poster preparation and oral presentation guidelines will be provided upon notification of presentation selection.
** Late Breaking Abstracts may still be considered for presentation at the discretion of the SOC.
Please email: info@CGT4HIVcure.org
Updated June 5, 2014